BioCentury
ARTICLE | Clinical News

VR475: Phase IIb/III data

January 26, 2015 8:00 AM UTC

The double-blind, European Phase IIb/III Acti-AICS-001 trial in 199 asthma patients dependent on oral corticosteroids showed that VR475 with a 1 mg dose of budesonide met the primary endpoint of a gre...